{"id":"https://openalex.org/W2804074801","doi":"https://doi.org/10.1371/journal.pone.0197213","title":"A multi-center preclinical study of gadoxetate DCE-MRI in rats as a biomarker of drug induced inhibition of liver transporter function","display_name":"A multi-center preclinical study of gadoxetate DCE-MRI in rats as a biomarker of drug induced inhibition of liver transporter function","publication_year":2018,"publication_date":"2018-05-17","ids":{"openalex":"https://openalex.org/W2804074801","doi":"https://doi.org/10.1371/journal.pone.0197213","mag":"2804074801","pmid":"https://pubmed.ncbi.nlm.nih.gov/29771932","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5957399"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0197213","doi":"https://doi.org/10.1371/journal.pone.0197213","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0197213","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0197213&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0197213&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019577060","display_name":"Anastassia Karageorgis","orcid":"https://orcid.org/0000-0003-1348-5580","observed_orcids":["https://orcid.org/0000-0003-1348-5580"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Anastassia Karageorgis","raw_affiliation_strings":["Safety and ADME Translational Sciences, Drug Safety and Metabolism, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":"https://orcid.org/0000-0003-1348-5580","affiliations":[{"raw_affiliation_string":"Safety and ADME Translational Sciences, Drug Safety and Metabolism, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061784506","display_name":"Stephen C. Lenhard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen C. Lenhard","raw_affiliation_strings":["Bioimaging, Platform Technology and Sciences, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioimaging, Platform Technology and Sciences, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083014913","display_name":"Brittany Yerby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brittany Yerby","raw_affiliation_strings":["Research Imaging Sciences, Amgen, Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Imaging Sciences, Amgen, Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034141087","display_name":"Mikael Fredrik Forsgren","orcid":"https://orcid.org/0000-0003-4630-6550","observed_orcids":["https://orcid.org/0000-0003-4630-6550"]},"institutions":[{"id":"https://openalex.org/I102134673","display_name":"Link\u00f6ping University","ror":"https://ror.org/05ynxx418","country_code":"SE","type":"education","lineage":["https://openalex.org/I102134673"]},{"id":"https://openalex.org/I4210113321","display_name":"Wolfram MathCore (Sweden)","ror":"https://ror.org/01zyxxc50","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210113321"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mikael F. Forsgren","raw_affiliation_strings":["Center for Medical Image Science and Visualization (CMIV), Department of Medical and Health Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden","Wolfram MathCore, Link\u00f6ping, Sweden","Center for Medical Image Science and Visualization (CMIV), Department of Medical and Health Sciences, Linko \u00a8ping University, Linko \u00a8ping, Sweden,","Wolfram MathCore, Linko \u00a8ping, Sweden,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Medical Image Science and Visualization (CMIV), Department of Medical and Health Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden","institution_ids":["https://openalex.org/I102134673"]},{"raw_affiliation_string":"Wolfram MathCore, Link\u00f6ping, Sweden","institution_ids":["https://openalex.org/I4210113321"]},{"raw_affiliation_string":"Center for Medical Image Science and Visualization (CMIV), Department of Medical and Health Sciences, Linko \u00a8ping University, Linko \u00a8ping, Sweden,","institution_ids":["https://openalex.org/I102134673"]},{"raw_affiliation_string":"Wolfram MathCore, Linko \u00a8ping, Sweden,","institution_ids":["https://openalex.org/I4210113321"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031605568","display_name":"Serguei M. Liachenko","orcid":"https://orcid.org/0000-0002-0683-5442","observed_orcids":["https://orcid.org/0000-0002-0683-5442"]},"institutions":[{"id":"https://openalex.org/I1304557061","display_name":"National Center for Toxicological Research","ror":"https://ror.org/05jmhh281","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1304557061","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Serguei Liachenko","raw_affiliation_strings":["National Center for Toxicological Research, Division of Neurotoxicology, United States Food and Drug Administration, Jefferson, Arkansas, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center for Toxicological Research, Division of Neurotoxicology, United States Food and Drug Administration, Jefferson, Arkansas, United States of America","institution_ids":["https://openalex.org/I1304557061","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074019339","display_name":"Edvin Johansson","orcid":"https://orcid.org/0000-0003-2515-2054","observed_orcids":["https://orcid.org/0000-0003-2515-2054"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Edvin Johansson","raw_affiliation_strings":["Personalised Healthcare and Biomarkers, Imaging group, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden","Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden,","Personalised Healthcare and Biomarkers, Imaging group,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Personalised Healthcare and Biomarkers, Imaging group, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden,","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Personalised Healthcare and Biomarkers, Imaging group,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029213343","display_name":"Mark Andrew Pilling","orcid":"https://orcid.org/0000-0002-7446-6597","observed_orcids":["https://orcid.org/0000-0002-7446-6597"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark A. Pilling","raw_affiliation_strings":["Biostatistics, Quantitative Biology, Discovery Sciences, Innovative Medicines and Early Development, AstraZeneca R&D, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics, Quantitative Biology, Discovery Sciences, Innovative Medicines and Early Development, AstraZeneca R&D, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard A. Peterson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard A. Peterson","raw_affiliation_strings":["Safety Assessment, GlaxoSmithKline, Research Triangle Park, Durham, North Carolina, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment, GlaxoSmithKline, Research Triangle Park, Durham, North Carolina, United States of America","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032132434","display_name":"Xi Yang","orcid":"https://orcid.org/0000-0002-3427-0565","observed_orcids":["https://orcid.org/0000-0002-3427-0565","https://orcid.org/0000-0003-0689-1417"]},"institutions":[{"id":"https://openalex.org/I1304557061","display_name":"National Center for Toxicological Research","ror":"https://ror.org/05jmhh281","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1304557061","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xi Yang","raw_affiliation_strings":["National Center for Toxicological Research, Division of Systems Biology, United States Food and Drug Administration, Jefferson, Arkansas, United States of America","Division of Systems Biology, United States Food and Drug Administration, Jefferson, Arkansas, United States of America,","National Center for Toxicological Research,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center for Toxicological Research, Division of Systems Biology, United States Food and Drug Administration, Jefferson, Arkansas, United States of America","institution_ids":["https://openalex.org/I1304557061","https://openalex.org/I1320320070"]},{"raw_affiliation_string":"Division of Systems Biology, United States Food and Drug Administration, Jefferson, Arkansas, United States of America,","institution_ids":["https://openalex.org/I1320320070"]},{"raw_affiliation_string":"National Center for Toxicological Research,","institution_ids":["https://openalex.org/I1304557061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063122845","display_name":"Dominic P. Williams","orcid":"https://orcid.org/0000-0002-0758-3152","observed_orcids":["https://orcid.org/0000-0002-0758-3152"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dominic P. Williams","raw_affiliation_strings":["Safety and ADME Translational Sciences, Drug Safety and Metabolism, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety and ADME Translational Sciences, Drug Safety and Metabolism, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019363566","display_name":"Sharon E. Ungersma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon E. Ungersma","raw_affiliation_strings":["Research Imaging Sciences, Amgen, Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Imaging Sciences, Amgen, Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076374753","display_name":"Ryan E. Morgan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan E. Morgan","raw_affiliation_strings":["Department of Comparative Biology and Safety Sciences, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Comparative Biology and Safety Sciences, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056589677","display_name":"Kim L. R. Brouwer","orcid":"https://orcid.org/0000-0003-1945-4929","observed_orcids":["https://orcid.org/0000-0003-1945-4929"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kim L. R. Brouwer","raw_affiliation_strings":["Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of N orth Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of N orth Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009295868","display_name":"Beat M. Jucker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beat M. Jucker","raw_affiliation_strings":["Bioimaging, Platform Technology and Sciences, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioimaging, Platform Technology and Sciences, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5137091790","display_name":"Paul D. Hockings","orcid":"https://orcid.org/0000-0002-7154-9047","observed_orcids":["https://orcid.org/0000-0002-7154-9047"]},"institutions":[{"id":"https://openalex.org/I4210115315","display_name":"Antaros Medical (Sweden)","ror":"https://ror.org/029v5hv47","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210115315"]},{"id":"https://openalex.org/I66862912","display_name":"Chalmers University of Technology","ror":"https://ror.org/040wg7k59","country_code":"SE","type":"education","lineage":["https://openalex.org/I66862912"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Paul D. Hockings","raw_affiliation_strings":["Antaros Medical, BioVenture Hub, M\u00f6lndal, Sweden","MedTech West, Chalmers University of Technology, Gothenburg, Sweden","Antaros Medical, BioVenture Hub, Mo \u00a8lndal, Sweden,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antaros Medical, BioVenture Hub, M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210115315"]},{"raw_affiliation_string":"MedTech West, Chalmers University of Technology, Gothenburg, Sweden","institution_ids":["https://openalex.org/I66862912"]},{"raw_affiliation_string":"Antaros Medical, BioVenture Hub, Mo \u00a8lndal, Sweden,","institution_ids":["https://openalex.org/I4210115315"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5019577060"],"corresponding_institution_ids":["https://openalex.org/I4210143795"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":1.1476,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.80265058,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"13","issue":"5","first_page":"e0197213","last_page":"e0197213"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.8550000190734863,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.8550000190734863,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.1071000024676323,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10378","display_name":"Advanced MRI Techniques and Applications","score":0.01850000023841858,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gadoxetate","display_name":"gadoxetate","score":0.9869999885559082},{"id":"https://openalex.org/keywords/drug-induced-liver-injury","display_name":"drug-induced liver injury","score":0.8009999990463257},{"id":"https://openalex.org/keywords/hepatobiliary-transporters","display_name":"hepatobiliary transporters","score":0.9549999833106995},{"id":"https://openalex.org/keywords/transporter-inhibition","display_name":"transporter inhibition","score":0.5109999775886536},{"id":"https://openalex.org/keywords/dynamic-contrast-enhanced-mri","display_name":"dynamic contrast-enhanced MRI","score":0.7720000147819519},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.847000002861023},{"id":"https://openalex.org/keywords/cholestasis","display_name":"cholestasis","score":0.6150000095367432},{"id":"https://openalex.org/keywords/pharmacokinetic-modeling","display_name":"pharmacokinetic modeling","score":0.8169999718666077}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7348849773406982},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.617158055305481},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5123358964920044},{"id":"https://openalex.org/C2776637226","wikidata":"https://www.wikidata.org/wiki/Q6658207","display_name":"Liver injury","level":2,"score":0.5019567012786865},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4948243498802185},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.4802177846431732},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.43542179465293884},{"id":"https://openalex.org/C2779609443","wikidata":"https://www.wikidata.org/wiki/Q1368191","display_name":"Liver transplantation","level":3,"score":0.4243931174278259},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4235479235649109},{"id":"https://openalex.org/C2992208098","wikidata":"https://www.wikidata.org/wiki/Q1359801","display_name":"Liver function","level":2,"score":0.42349645495414734},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.4219609498977661},{"id":"https://openalex.org/C2778593092","wikidata":"https://www.wikidata.org/wiki/Q1075923","display_name":"Cholestasis","level":2,"score":0.42117050290107727},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3650076389312744},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3035658597946167},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.3023729920387268},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.20753982663154602},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.18443602323532104},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1831156611442566},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08920928835868835},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001693","descriptor_name":"Biological Transport, Active","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003287","descriptor_name":"Contrast Media","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003287","descriptor_name":"Contrast Media","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019786","descriptor_name":"Gadolinium DTPA","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019786","descriptor_name":"Gadolinium DTPA","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1371/journal.pone.0197213","doi":"https://doi.org/10.1371/journal.pone.0197213","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0197213","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0197213&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},{"id":"pmid:29771932","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29771932","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5957399","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5957399/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmh:oai:DiVA.org:liu-148072","doi":null,"is_oa":true,"landing_page_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-148072","pdf_url":null,"source":{"id":"https://openalex.org/S4306400838","display_name":"DiVA (Linkoping University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I102134673","host_organization_name":"Link\u00f6ping University","host_organization_lineage":["https://openalex.org/I102134673"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:e86a20e0eb874265853c1800292d563c","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/e86a20e0eb874265853c1800292d563c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 13, Iss 5, p e0197213 (2018)","raw_type":"article"},{"id":"pmh:oai:research.chalmers.se:530627","doi":null,"is_oa":false,"landing_page_url":"https://research.chalmers.se/en/publication/530627","pdf_url":null,"source":{"id":"https://openalex.org/S4306402469","display_name":"Chalmers Research (Chalmers University of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66862912","host_organization_name":"Chalmers University of Technology","host_organization_lineage":["https://openalex.org/I66862912"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},{"id":"pmh:oai:www.repository.cam.ac.uk:1810/276387","doi":null,"is_oa":true,"landing_page_url":"https://www.repository.cam.ac.uk/handle/1810/276387","pdf_url":null,"source":{"id":"https://openalex.org/S4306401777","display_name":"Apollo (University of Cambridge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I241749","host_organization_name":"University of Cambridge","host_organization_lineage":["https://openalex.org/I241749"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"doi:10.17863/cam.23690","doi":"https://doi.org/10.17863/cam.23690","is_oa":true,"landing_page_url":"https://doi.org/10.17863/cam.23690","pdf_url":null,"source":{"id":"https://openalex.org/S7407050737","display_name":"Apollo","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0197213","doi":"https://doi.org/10.1371/journal.pone.0197213","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0197213","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0197213&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3230350167","display_name":"Altered Hepatic Disposition of Anionic Drugs-Mechanisms","funder_award_id":"R01GM041935","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G9000901949","display_name":"Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy","funder_award_id":"R35GM122576","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320310698","display_name":"Health and Environmental Sciences Institute","ror":"https://ror.org/006x8s867"},{"id":"https://openalex.org/F4320320303","display_name":"Bayer HealthCare","ror":"https://ror.org/04hmn8g73"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"},{"id":"https://openalex.org/F4320332600","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2804074801.pdf","grobid_xml":"https://content.openalex.org/works/W2804074801.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W1550119222","https://openalex.org/W1551454073","https://openalex.org/W1595159159","https://openalex.org/W1836939882","https://openalex.org/W1964456351","https://openalex.org/W1964477426","https://openalex.org/W1973189339","https://openalex.org/W1980440335","https://openalex.org/W1985573007","https://openalex.org/W1988499440","https://openalex.org/W1993510618","https://openalex.org/W2001112876","https://openalex.org/W2001858411","https://openalex.org/W2004947604","https://openalex.org/W2006251874","https://openalex.org/W2006340667","https://openalex.org/W2009055300","https://openalex.org/W2011435635","https://openalex.org/W2021233291","https://openalex.org/W2022514814","https://openalex.org/W2023922443","https://openalex.org/W2027998159","https://openalex.org/W2030003406","https://openalex.org/W2034266527","https://openalex.org/W2037243689","https://openalex.org/W2044498526","https://openalex.org/W2054863356","https://openalex.org/W2062430699","https://openalex.org/W2064889561","https://openalex.org/W2082303266","https://openalex.org/W2083072749","https://openalex.org/W2084848944","https://openalex.org/W2089041588","https://openalex.org/W2090699169","https://openalex.org/W2104000264","https://openalex.org/W2104209550","https://openalex.org/W2106659994","https://openalex.org/W2108266528","https://openalex.org/W2115869678","https://openalex.org/W2119671639","https://openalex.org/W2128846086","https://openalex.org/W2131423161","https://openalex.org/W2134956122","https://openalex.org/W2142224741","https://openalex.org/W2150060563","https://openalex.org/W2153247789","https://openalex.org/W2156466311","https://openalex.org/W2156853890","https://openalex.org/W2162446290","https://openalex.org/W2510983770","https://openalex.org/W2517844655","https://openalex.org/W4238386383"],"related_works":["https://openalex.org/W4411397243","https://openalex.org/W1550119222","https://openalex.org/W4404744840","https://openalex.org/W2804236624","https://openalex.org/W4410157821","https://openalex.org/W7205405806","https://openalex.org/W4313639549","https://openalex.org/W2540046932","https://openalex.org/W4401364463","https://openalex.org/W2567618481"],"abstract_inverted_index":{"Drug-induced":[0],"liver":[1,10,226],"injury":[2],"(DILI)":[3],"is":[4,180,190],"a":[5,67,181],"leading":[6],"cause":[7],"of":[8,19,57,66,70,151,161,169,199,225],"acute":[9],"failure":[11],"and":[12,28,55,101,131,148,166,202,206],"transplantation.":[13],"DILI":[14],"can":[15],"be":[16],"the":[17,58,64,71,87,110,120,133,146,158,167,177,194],"result":[18],"impaired":[20],"hepatobiliary":[21,46,214],"transporters,":[22],"with":[23,41],"altered":[24],"bile":[25],"formation,":[26],"flow,":[27],"subsequent":[29],"cholestasis.":[30],"We":[31],"used":[32],"gadoxetate":[33,82,115,152,200],"dynamic":[34],"contrast-enhanced":[35],"magnetic":[36],"resonance":[37],"imaging":[38,78],"(DCE-MRI),":[39],"combined":[40],"pharmacokinetic":[42],"modelling,":[43],"to":[44,193,209,222],"measure":[45],"transporter":[47,215],"function":[48,216],"in":[49,51,74,213,217,219],"vivo":[50,218],"rats.":[52],"The":[53,80,113],"sensitivity":[54],"robustness":[56],"method":[59,189],"was":[60,93,123,137,174],"tested":[61],"by":[62,157],"evaluating":[63],"effect":[65,173],"clinical":[68,159],"dose":[69,160],"antibiotic":[72],"rifampicin":[73,111,134,162],"four":[75],"different":[76],"preclinical":[77],"centers.":[79,178],"mean":[81,114],"uptake":[83,147,201],"rate":[84,117],"constant":[85,118],"for":[86,109,119,132],"vehicle":[88,121],"groups":[89,122,136],"at":[90,163],"all":[91,164],"centers":[92,165],"39.3":[94],"+/-":[95,103,125,139],"3.4":[96],"s-1":[97,105,127,141],"(n":[98,106,128,142],"=":[99,107,129,143],"23)":[100,130],"11.7":[102],"1.3":[104],"20)":[108],"groups.":[112],"efflux":[116],"1.53":[124],"0.08":[126,140],"treated":[135],"0.94":[138],"20).":[144],"Both":[145],"excretion":[149,203],"transporters":[150],"were":[153],"statistically":[154],"significantly":[155],"inhibited":[156],"size":[168],"this":[170,188],"treatment":[171],"group":[172],"consistent":[175],"across":[176],"Gadoxetate":[179],"clinically":[182],"approved":[183],"MRI":[184],"contrast":[185],"agent,":[186],"so":[187],"readily":[191],"transferable":[192],"clinic.":[195],"CONCLUSION:":[196],"Rate":[197],"constants":[198],"are":[204],"sensitive":[205],"robust":[207],"biomarkers":[208,224],"detect":[210],"early":[211],"changes":[212],"rats":[220],"prior":[221],"established":[223],"toxicity.":[227]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2018-06-01T00:00:00"}